| Mouse type | T cells | B cells | NK cells | Coat | Other Notes |
|---|---|---|---|---|---|
| CD1 | No | Yes | Yes | White/albino | Outbred |
| B6 | Yes | Yes | Yes | White/albino | Inbred |
| Balb/C | No | Yes | Yes | Nude, albino | Inbred |
| Balb/SCID | No | No | Yes | White | Inbred |
| NOD/SCID | No | No | Impaired | White | Inbred |
| Nu/Nu | No | Yes | Yes | Nude | Outbred |
| CD57BL | Yes | Yes | Yes | Dark brown/black | Inbred |
| CB17 | Yes | Yes | Yes | White | Inbred |
| NSG | No | No | No | White | Inbred |
| Swiss Nude | No | Yes | Yes | Nude | Outbred |
CD1 Mouse Model
Overview of the CD1 Mouse Strain
The CD1 mouse strain is an outbred albino model widely used in biomedical research for its genetic diversity, vigorous health, and excellent breeding capacity. Originating from Swiss stock, CD1 mice are highly favored for applications that require large cohorts and reproducibility across diverse genetic backgrounds. Their robust immune function, large body size, and adaptability make them well-suited for pharmacological, toxicological, and in vivo gene delivery studies. Unlike inbred strains, CD1 mice better reflect human population variability, which is particularly valuable for translational studies in drug safety, metabolism, and immunology.
Immunological Characteristics
CD1 mice possess active B cells and functional natural killer (NK) cells, but they lack mature T cells. This unique immunological profile results in partial immunodeficiency, allowing for the engraftment of certain allogeneic and xenogeneic cells while still retaining elements of innate immune surveillance. The absence of T cells reduces graft rejection, while the presence of NK cells supports studies of innate immunity and immunotherapeutic mechanisms. This makes CD1 mice useful for exploring immune responses, tumor progression, and therapeutic resistance in models where selective immune suppression is beneficial without complete immunodeficiency.
Applications in In Vivo Gene Delivery and Transfection
CD1 mice are compatible with a variety of in vivo transfection techniques, including nanoparticle systems, lipid-based reagents, and polymer carriers. Their relatively large body size allows for high-volume systemic administration via intravenous injection, a crucial factor for liver, lung, and spleen targeting. CD1 mice are routinely used in studies evaluating plasmid DNA, siRNA, shRNA, mRNA, and CRISPR-Cas9 delivery. Their physiology allows for reproducible assessment of biodistribution, organ-specific gene silencing, and protein expression across multiple organs. Transfection studies involving these mice often use tail vein injections or localized delivery methods to measure gene modulation in organs such as the pancreas, brain, kidney, and lung. Altogen Biosystems offers a suite of specialized in vivo transfection reagents that are fully compatible with CD1 mice, including nanoparticle, polymer, and liposome formulations that support high-efficiency delivery with low cytotoxicity.
Role in Toxicology and Preclinical Drug Testing
Due to their genetic heterogeneity, CD1 mice are highly suited for preclinical toxicology and pharmacokinetic studies. They are commonly used in OECD-compliant testing protocols for acute toxicity, repeated-dose toxicity, developmental toxicity, and dermal or inhalation safety studies. CD1 mice have predictable pharmacokinetics, strong metabolic capacity, and are frequently used in support of Investigational New Drug (IND) applications. Their use in regulatory toxicology helps bridge the gap between animal data and human safety predictions. Their capacity to handle varied drug administration routes and formulations makes them a preferred model for systemic exposure studies and compound safety validation.
Utility in Tumor and Xenograft Research
Although CD1 mice are not fully immunodeficient, their lack of mature T cells allows for limited xenograft acceptance under controlled conditions. They are suitable for certain tumor models, especially when evaluating innate immune responses, cytokine dynamics, and antibody-mediated cytotoxicity. Their large body size and surgical tolerance allow for subcutaneous and orthotopic tumor implantation procedures with consistent growth profiles. CD1 mice support research on tumor biology, immune infiltration, and combinatorial therapy involving chemotherapy and immunomodulatory agents. They also serve as valuable controls in immune-tumor interaction studies where full immunosuppression is not required.
Research Applications and Recommendations
CD1 mice are an excellent choice for researchers requiring a resilient and genetically diverse model for in vivo gene delivery, pharmacological profiling, or early-stage therapeutic screening. Their immune profile permits flexible experimental designs involving gene silencing, overexpression, and immune regulation without the full constraints of complete immunodeficiency. Their use in transfection studies, RNAi delivery, nanoparticle development, and safety pharmacology ensures broad utility across academic, biotech, and pharmaceutical research settings. Altogen Labs provides comprehensive in vivo RNA interference services and transfection experiments using CD1 mice, including tissue-specific delivery, formulation development, endpoint analysis, and gene expression validation.
Learn More at Altogen Labs
To explore xenograft models using CD1 and other mouse strains, visit Altogen Labs at https://altogenlabs.com/xenograft-models/.
B6 Mouse Model
Overview of the C57BL/6 Mouse Strain
The C57BL/6 mouse (commonly referred to as B6) is one of the most widely used inbred strains in biomedical research. Its well-characterized genome, robust immune function, and suitability for genetic manipulation have made it a foundational model across disciplines such as immunology, oncology, neurobiology, and metabolic disease. With a white/albino coat and homozygous genetic background, B6 mice are ideal for reproducible experiments, consistent transgene expression, and controlled comparison of therapeutic interventions. Their availability in a wide range of genetically engineered variants—including knockout, knock-in, and reporter lines—supports both basic and translational research.
Immunological Profile and Functional Relevance
C57BL/6 mice possess a fully functional immune system, including active T cells, B cells, and natural killer (NK) cells. This complete immunocompetence makes them essential for studying immune-mediated diseases, autoimmunity, vaccine development, and host-pathogen interactions. Unlike immunodeficient strains, B6 mice retain the ability to mount adaptive and innate immune responses, enabling detailed investigations into cytokine signaling, T cell differentiation, and antibody production. Their use in immuno-oncology and inflammation research continues to grow due to their reliability in modeling physiological immune responses and their responsiveness to checkpoint inhibitors, monoclonal antibodies, and cellular therapies.
Applications in DNA and RNA In Vivo Transfection
B6 mice are highly compatible with advanced in vivo transfection technologies. Their consistent physiology and robust organ systems make them suitable for gene delivery via systemic or localized injection. They are frequently used in studies involving plasmid DNA, siRNA, shRNA, miRNA, and CRISPR-Cas9 delivery systems. Transfection methods often include intravenous tail vein injection, intraperitoneal administration, or intramuscular electroporation to achieve tissue-specific expression or knockdown. B6 mice are ideal for evaluating gene modulation in organs such as the liver, lung, spleen, kidney, and brain. Altogen Biosystems offers transfection reagents formulated for optimal delivery efficiency and minimal toxicity in B6 mice, including nanoparticle, polymer, and lipid-based kits that ensure reliable nucleic acid transfer.
Genetic Engineering and Transgenic Model Use
The C57BL/6 background is the gold standard for generating genetically modified mouse models. Their genome has been fully sequenced, and they are the most common recipient strain for embryonic stem (ES) cell-based gene targeting. Thousands of transgenic and knockout lines have been developed using the B6 strain, making it possible to model nearly every major human disease. From metabolic disorders and neurodegeneration to cancer and cardiovascular disease, B6 mice allow precise interrogation of gene function, drug mechanisms, and molecular signaling pathways. Their predictable response to targeted siRNA and shRNA therapies also makes them ideal for evaluating RNA interference (RNAi) therapeutics.
Use in Toxicology and Pharmacology Studies
Due to their defined genetics and reproducible physiology, B6 mice are widely used in regulatory toxicology and pharmacokinetics. They are suitable for standard OECD-compliant safety studies, including acute and chronic toxicity, developmental toxicity, and carcinogenicity testing. Their metabolic and immune systems enable accurate modeling of compound bioavailability, systemic exposure, and immune-mediated adverse effects. B6 mice are commonly used to establish dose–response relationships, perform IC50 analysis for tumor models, and evaluate safety pharmacology endpoints such as organ histopathology, hematology, and serum biomarkers. In IND-enabling studies, B6 mice provide critical preclinical data that predict therapeutic safety and efficacy in human clinical trials.
Oncology and Tumor Xenograft Applications
C57BL/6 mice are frequently used in syngeneic tumor models, where cancer cell lines derived from the same strain are implanted to preserve immune system interactions. This approach enables realistic assessment of immunotherapies, checkpoint blockade, and tumor–immune dynamics. Although B6 mice are not suitable for xenograft models involving human tumor cell lines due to immune rejection, they are ideal for murine tumor studies that require immune surveillance. In cancer research, they are often used alongside immunodeficient strains to compare immune-dependent and immune-independent mechanisms of tumor progression and treatment response.
Preclinical Research Advantages
Researchers benefit from the stability, predictability, and broad applicability of B6 mice across a wide range of experimental platforms. Their use in DNA and RNA transfection studies, gene therapy validation, immunopharmacology, and toxicology enhances reproducibility and scientific rigor. B6 mice allow for consistent delivery and expression of nucleic acid-based therapeutics, making them valuable in the development of vaccines, mRNA therapies, RNAi agents, and CRISPR-based tools. Their responsiveness to standard laboratory protocols makes them efficient and cost-effective for routine use in preclinical pipelines.
Services Supporting B6 Mouse Research
Altogen Biosystems offers a range of in vivo transfection products tailored for high-performance delivery in C57BL/6 mice. These include PEGylated liposomes, cationic polymers, and nanoparticle-based reagents designed to overcome biological barriers to nucleic acid delivery. For advanced experimental designs, Altogen Labs provides fully managed in vivo RNAi services, including formulation, dosing, tissue targeting, gene knockdown validation, and phenotypic analysis using B6 mice. Studies involving immune modulation, gene expression, or toxicity can be performed under GLP-compliant conditions with customized protocols developed to meet the goals of both academic and pharmaceutical research projects.
Learn More at Altogen Labs
To explore xenograft models and in vivo services involving B6 and other mouse strains, visit Altogen Labs at https://altogenlabs.com/xenograft-models/.
Balb/C Mouse Model
Overview of the Balb/C Mouse Strain
The Balb/C mouse strain is a widely utilized inbred model in immunology, oncology, infectious disease, and gene therapy research. Originating from albino stock over a century ago, Balb/C mice have been extensively characterized and are notable for their consistent behavior, high breeding efficiency, and reproducible physiological responses. Their albino phenotype and nude variant make them particularly advantageous for imaging studies and subcutaneous tumor implantation. Balb/C mice serve as a foundational tool for researchers investigating immune mechanisms, tumor biology, and in vivo gene delivery due to their immunocompetent status and widespread availability.
Immunological Characteristics and Research Utility
Balb/C mice are known for their Th2-skewed immune response, favoring humoral immunity over cell-mediated immunity. While they do not possess functional T cells, they retain fully functional B cells and natural killer (NK) cells, allowing for a range of immunological studies focused on antibody production, cytokine signaling, and innate immune responses. This immune profile makes them useful for evaluating allergic reactions, autoimmune conditions, and humoral immune responses to gene-based vaccines or therapeutics. Their susceptibility to certain pathogens and tumors also makes them a valuable model for studying infectious disease progression and tumor–host interactions in an immunologically permissive environment.
Applications in DNA and RNA Transfection Studies
Balb/C mice are frequently used in studies requiring high-efficiency in vivo transfection of DNA or RNA. Their genetic stability and predictable response to nucleic acid delivery technologies make them an optimal choice for evaluating in vivo transfection reagents. They are compatible with a variety of delivery routes including intravenous, intramuscular, and intratumoral administration. Balb/C mice are commonly used in experiments involving plasmid DNA, siRNA, shRNA, and mRNA delivery for therapeutic gene modulation, reporter gene expression, and functional gene silencing. Altogen Biosystems provides optimized transfection reagents—including polymeric and liposomal systems—formulated for use in albino mouse strains like Balb/C to ensure high transfection efficiency and minimal off-target effects.
Oncology Applications and Tumor Xenografts
The Balb/C strain is particularly valuable in oncology due to its permissiveness to tumor growth. It is commonly used for subcutaneous and orthotopic implantation of murine tumor cell lines, supporting robust and consistent tumor formation. While Balb/C mice are immunocompetent, their nude variants (Balb/C-nu/nu) lack functional T cells, making them ideal for xenograft studies involving human cancer cell lines. These models are used to assess tumor progression, angiogenesis, drug efficacy, and gene therapy delivery in an immunodeficient background that does not reject human cells. Balb/C xenograft models are frequently used in preclinical trials for evaluating novel anticancer compounds and gene modulation therapies.
Use in Toxicology and Pharmacokinetics
Balb/C mice are suitable for safety pharmacology and toxicology studies, especially when studying agents that interact with B cells or NK cell pathways. Their stable physiology and reproducible response to pharmacologic agents make them effective models for evaluating systemic toxicity, biodistribution, and tissue-specific drug accumulation. In vivo gene delivery studies using Balb/C mice support the development of nucleic acid-based therapeutics, including mRNA vaccines and siRNA-based gene knockdown platforms. Their use in metabolism and pharmacokinetic profiling ensures accurate prediction of therapeutic exposure and clearance rates in translational research.
Genetic Research and Gene Expression Models
While not as frequently used as C57BL/6 mice for transgenic model development, Balb/C mice are compatible with gene editing tools such as CRISPR/Cas9 for developing gene knockdown and knockout lines. They are routinely employed in studies requiring consistent gene expression following in vivo delivery of transgenes via plasmid DNA or viral vectors. These features make them suitable for validating gene regulatory elements, tissue-specific promoters, and functional gene perturbation tools in the context of in vivo systems.
Support Services and Reagent Solutions
Altogen Biosystems offers specialized in vivo transfection kits compatible with Balb/C mouse physiology. These include nanoparticle- and polymer-based delivery systems engineered for high efficiency and minimal cytotoxicity in albino strains. Kits are designed to support DNA, siRNA, shRNA, and miRNA delivery for use in a range of tissues including liver, muscle, pancreas, and tumor sites. For more complex studies, Altogen Labs provides in vivo RNAi and gene delivery services using Balb/C and Balb/C nude mouse models. These services include study design, formulation development, animal dosing, molecular endpoint analysis, and histological assessment under GLP-compliant protocols.
Learn More at Altogen Labs
To explore xenograft and in vivo transfection services using Balb/C mouse models, visit Altogen Labs at https://altogenlabs.com/xenograft-models/.
Balb/SCID Mouse Model
Overview of the Balb/SCID Strain
The Balb/SCID (Severe Combined Immunodeficiency) mouse is a genetically engineered inbred strain derived from the Balb/C background that lacks functional T and B lymphocytes. As a result of the Prkdc^scid mutation affecting V(D)J recombination, these mice are incapable of mounting an adaptive immune response. Balb/SCID mice retain natural killer (NK) cell activity, providing partial innate immunity while remaining severely immunodeficient. Their albino phenotype and immunocompromised status make them a valuable tool in xenograft studies, human cell transplantation, and in vivo gene therapy research. Their genetic uniformity and reproducible responses make them a cornerstone model in preclinical biotechnology and oncology research.
Immunodeficiency Profile and Experimental Advantages
The complete absence of mature T and B cells in Balb/SCID mice makes them highly permissive to xenotransplantation of human tumor cells, stem cells, and primary tissues. Unlike nude mice, which lack only T cells, SCID mice exhibit more profound immunosuppression, allowing longer engraftment periods and reduced host rejection. Despite functional NK cell activity, they remain highly susceptible to a wide variety of viral and bacterial infections, necessitating specific-pathogen-free (SPF) housing conditions in research settings. This immunodeficiency is crucial for experiments requiring a non-reactive host environment, such as in vivo gene modulation and the evaluation of human-specific therapies.
Applications in In Vivo Transfection Studies
Balb/SCID mice are commonly used in studies involving in vivo nucleic acid delivery, including siRNA, shRNA, plasmid DNA, and CRISPR components. Their immunodeficient background minimizes clearance of foreign genetic materials, supporting more efficient delivery and sustained expression of transgenes. Altogen Biosystems provides proprietary transfection reagents suitable for use in SCID mice, including polymer- and lipid-based formulations engineered for low immunogenicity and high uptake in immunocompromised models. These tools are essential for investigating gene knockdown, overexpression, or genome editing in oncology, infectious disease, and regenerative medicine.
Use in Human Tumor Xenograft Models
The Balb/SCID mouse is one of the most widely used hosts for establishing human tumor xenograft models due to its ability to support rapid tumor growth without immune rejection. Solid tumors derived from lung, breast, ovarian, pancreatic, colorectal, and hematological malignancies are routinely implanted subcutaneously or orthotopically into SCID mice. These models allow for robust testing of anticancer agents, gene-targeted therapies, and RNAi-based therapeutics. The presence of NK cell activity also makes Balb/SCID mice useful for investigating tumor–innate immune system interactions in the absence of adaptive immunity.
Suitability for Pharmacology and Toxicology
Balb/SCID mice are employed in preclinical pharmacokinetic and toxicology studies involving gene therapy and nanoparticle-based formulations. Their impaired immunity allows for prolonged circulation of gene delivery systems, facilitating the study of tissue distribution, off-target effects, and sustained gene expression profiles. They are also useful in evaluating immune-related adverse events associated with humanized therapies or biologics. Pharmacological assessments in SCID mice can provide valuable data in the development of RNAi-based drugs, particularly in assessing in vivo efficacy, bioavailability, and cellular responses.
Genetic and Molecular Biology Applications
Researchers frequently use Balb/SCID mice to assess gene function in vivo using transient or stable gene transfer techniques. Due to the permissiveness of these mice to human cells, they serve as hosts for patient-derived xenograft (PDX) models and in vivo gene manipulation platforms. They are suitable for testing siRNA and shRNA constructs targeting oncogenes, tumor suppressor genes, and cytokine signaling pathways. Their use in RNAi studies is bolstered by compatibility with Altogen’s in vivo transfection reagents, which are optimized to minimize toxicity and maximize cytoplasmic delivery.
Supporting Products and Services
Altogen Biosystems offers a complete suite of in vivo transfection reagents suitable for use with Balb/SCID mouse models. These include targeted formulations for liver, lung, pancreas, and tumor-specific delivery. Additionally, Altogen Labs provides full-service preclinical studies using SCID mice, including xenograft model development, in vivo gene silencing, therapeutic evaluation, and endpoint molecular analysis. Studies can be tailored to meet regulatory standards and customized based on the target gene or delivery route, offering robust platforms for oncology and gene therapy research.
Learn More at Altogen Labs
To explore specialized services involving Balb/SCID xenograft models and in vivo RNAi experiments, visit Altogen Labs at https://altogenlabs.com/xenograft-models/.
NOD/SCID Mouse Model
Overview of the NOD/SCID Strain
The NOD/SCID mouse model combines two distinct immunodeficient genetic backgrounds—Non-Obese Diabetic (NOD) and Severe Combined Immunodeficiency (SCID)—resulting in a profoundly immunocompromised strain extensively used in biomedical research. This inbred strain lacks functional T cells and B cells due to the SCID mutation, while the NOD background impairs innate immune functions, including defective natural killer (NK) cell activity, complement deficiency, and macrophage dysfunction. The combination of adaptive and innate immune deficiencies makes NOD/SCID mice an exceptional host for human cell and tissue engraftment, allowing superior acceptance and growth of xenografts compared to other immunodeficient strains.
Immunodeficiency Characteristics and Experimental Utility
NOD/SCID mice exhibit near-complete immune system ablation, with severely impaired lymphocyte development and compromised innate immunity. The defective NK cell activity is a critical feature that reduces the clearance of transplanted human cells, thereby enabling enhanced engraftment efficiency for hematopoietic stem cells, cancer cells, and other primary human tissues. This strain is highly valuable for modeling human immune diseases, hematologic malignancies, and solid tumor biology. The severe immunodeficiency necessitates maintaining mice under specific-pathogen-free (SPF) conditions to minimize infection risk.
Applications in In Vivo Transfection and Gene Therapy Research
NOD/SCID mice are widely used for in vivo nucleic acid delivery studies, including siRNA, shRNA, plasmid DNA, and CRISPR/Cas9-based genome editing. Their severely compromised immune system prevents rapid immune-mediated clearance of foreign nucleic acids, promoting efficient and sustained gene silencing or expression. Altogen Biosystems offers tailored in vivo transfection reagents optimized for use in NOD/SCID models, facilitating efficient delivery with minimal toxicity. These reagents are critical tools for studying gene function, validating therapeutic targets, and developing RNA interference (RNAi)-based treatments in vivo.
Role in Human Xenograft and Patient-Derived Xenograft (PDX) Models
The NOD/SCID strain is a gold standard host for human tumor xenografts and patient-derived xenograft models due to its ability to support robust tumor establishment and growth without host immune rejection. This model is particularly important for studying cancers such as leukemia, lymphoma, breast, lung, pancreatic, and colorectal cancers. The lack of NK cell activity enhances engraftment success compared to Balb/SCID mice, making NOD/SCID ideal for long-term tumor studies and therapeutic efficacy evaluations. Researchers use this model to assess pharmacodynamics, drug resistance mechanisms, and gene-targeted therapies in a human-like tumor microenvironment.
Pharmacology, Toxicology, and Preclinical Research Utility
Due to their immunodeficient status, NOD/SCID mice are instrumental in preclinical studies involving novel therapeutics, including RNAi drugs, gene therapies, and biologics. They enable comprehensive pharmacokinetic and toxicological assessments, focusing on biodistribution, off-target effects, and treatment-related toxicities. Their use in safety pharmacology facilitates evaluation of immune-related adverse effects in the absence of adaptive immunity. Altogen Labs provides specialized pharmacology and toxicology testing services utilizing NOD/SCID models to generate robust preclinical data supporting IND filings and regulatory compliance.
Genetic Engineering and Molecular Biology Applications
NOD/SCID mice serve as platforms for stable and transient gene knockdown experiments using shRNA or siRNA technologies. The strain’s permissiveness to human hematopoietic and tumor cells allows for in vivo functional genomics studies targeting oncogenes, immune modulators, and signaling pathways. Altogen Biosystems’ in vivo transfection kits are specifically formulated to maximize delivery efficiency and gene silencing in NOD/SCID mice, supporting advanced research in cancer biology, immunology, and regenerative medicine.
Supportive Products and Professional Services
Altogen Biosystems supplies a range of in vivo transfection reagents and kits compatible with NOD/SCID mice, including lipid-based, polymeric, and nanoparticle formulations tailored for tissue-specific delivery. Complementing these products, Altogen Labs offers comprehensive contract research services covering xenograft establishment, in vivo gene delivery, therapeutic evaluation, and endpoint molecular analyses using NOD/SCID mice. Their expertise ensures reproducible, high-quality data for translational research and drug development pipelines.
Learn More at Altogen Labs
For detailed information and access to specialized services involving NOD/SCID xenograft models and in vivo RNAi delivery, visit Altogen Labs at https://altogenlabs.com/xenograft-models/.
Nu/Nu Mouse Model
Overview of the Nu/Nu Strain
The Nu/Nu mouse, commonly known as the nude mouse, is a widely used immunodeficient model characterized by a mutation in the Foxn1 gene that results in the absence of a thymus. This genetic defect leads to a severe deficiency in T lymphocytes, while B cells and natural killer (NK) cells remain functional. Nu/Nu mice exhibit a hairless phenotype, which facilitates tumor monitoring and in vivo imaging studies. Due to their compromised adaptive immunity, these mice are invaluable for engraftment of human tissues and cells, particularly in oncology, immunology, and regenerative medicine research.
Immunological Characteristics and Experimental Advantages
The absence of mature T cells in Nu/Nu mice severely impairs cell-mediated immunity, making them susceptible to xenotransplantation of human cells without rejection. However, their intact B cell and NK cell compartments allow for partial innate immune responses, which can influence engraftment success and experimental outcomes. Their immunodeficient status requires maintenance in sterile or specific-pathogen-free (SPF) conditions to prevent opportunistic infections. The hairless phenotype aids in visualizing tumor growth, wound healing, and tissue regeneration directly, enhancing the utility of Nu/Nu mice in longitudinal studies.
Applications in Cancer and Xenograft Research
Nu/Nu mice serve as a foundational model for human tumor xenograft studies, including cell line-derived xenografts and patient-derived xenografts (PDX). Their immune profile permits engraftment of various solid tumors such as breast, prostate, lung, and melanoma cancers. The model is extensively used to evaluate anticancer drug efficacy, tumor biology, metastasis, and tumor microenvironment interactions. While lacking T cell-mediated immune rejection, residual NK cell activity can sometimes limit xenograft growth, an aspect researchers consider when selecting this strain for experiments.
Use in In Vivo Transfection and Gene Silencing Studies
The Nu/Nu mouse is a preferred host for in vivo gene delivery applications including siRNA, shRNA, plasmid DNA, and CRISPR-Cas9 systems. Its immunodeficiency reduces immune-mediated clearance of nucleic acid therapeutics, promoting enhanced gene expression or silencing in target tissues. Altogen Biosystems offers specialized in vivo transfection reagents optimized for use in Nu/Nu mice, ensuring efficient and reproducible delivery with minimal toxicity. These reagents enable researchers to investigate gene function, validate targets, and develop RNA interference (RNAi)-based therapeutics within a live organism context.
Pharmacology and Toxicology Applications
Nu/Nu mice are integral to preclinical pharmacology and toxicology studies involving biological drugs, nucleic acid-based therapies, and small molecules. Their immunodeficient background facilitates investigation of drug effects on human tumor xenografts and humanized tissue models without confounding immune responses. This model supports pharmacokinetic, pharmacodynamic, and safety evaluations crucial for therapeutic development. Altogen Labs provides professional services using Nu/Nu mice to generate high-quality preclinical data, supporting regulatory submissions and IND applications.
Genetic Engineering and Functional Genomics
Nu/Nu mice enable stable and transient gene knockdown experiments, permitting researchers to study oncogenic pathways, immune modulation, and gene function in vivo. The strain’s compatibility with human cells supports mechanistic studies of disease progression and therapeutic responses. Altogen Biosystems supplies a range of in vivo transfection kits and reagents formulated for use with Nu/Nu mice, facilitating high-efficiency gene delivery tailored to specific experimental goals.
Support from Altogen Biosystems and Altogen Labs
Altogen Biosystems offers an extensive portfolio of in vivo transfection reagents compatible with the Nu/Nu mouse model, including lipid-based and polymeric formulations designed for optimal delivery to diverse tissues. Altogen Labs complements these products with contract research services encompassing xenograft model establishment, gene delivery, therapeutic evaluation, and molecular endpoint analyses. Their expertise ensures reproducible and translatable results critical for advancing translational research and drug discovery.
Learn More at Altogen Labs
To explore detailed services and products related to Nu/Nu mouse xenograft models and in vivo transfection, visit Altogen Labs at https://altogenlabs.com/xenograft-models/.
CD57BL Mouse Model
Overview of the CD57BL Strain
The CD57BL mouse model is an inbred strain widely utilized in immunological, oncology, and genetic research due to its robust immune system and defined genetic background. Known for its dark brown to black coat, CD57BL mice possess fully functional T cells, B cells, and natural killer (NK) cells, making them a valuable model for studies requiring a competent immune system. Their use in transplantation, infectious disease, and cancer immunotherapy research stems from their ability to mount complex immune responses, offering insights into immune regulation and tumor-host interactions.
Immunological Profile and Research Applications
CD57BL mice exhibit a complete and mature immune system with active adaptive and innate immune components. The presence of functional T lymphocytes, B lymphocytes, and NK cells enables detailed studies of cellular immunity, antibody production, and cytotoxic responses. This strain is instrumental in investigating immune responses to pathogens, vaccine efficacy, autoimmunity, and tumor immunology. Their immunocompetence also makes them suitable for evaluating immunomodulatory drugs and therapeutic interventions in preclinical research.
Use in Transplantation and Tumor Biology Studies
The CD57BL strain serves as a standard host for syngeneic transplantation models, where immune compatibility is essential for studying graft acceptance or rejection. It is also widely used for cancer research, including tumor implantation and immune checkpoint inhibitor studies, due to its intact immune surveillance mechanisms. Researchers employ CD57BL mice to assess tumor growth kinetics, metastatic potential, and the impact of immunotherapies on tumor microenvironments. Their immune competency provides a relevant system for modeling human immune responses in vivo.
Role in In Vivo Gene Delivery and Functional Genomics
The fully functional immune system of CD57BL mice presents unique challenges and opportunities for in vivo gene delivery experiments. While the immune system can potentially recognize and clear foreign nucleic acids or vectors, this strain allows assessment of immune activation, toxicity, and therapeutic efficacy in an immunocompetent setting. Altogen Biosystems provides specialized transfection reagents optimized for use in CD57BL mice, enabling efficient delivery of siRNA, miRNA, DNA, and protein cargos while minimizing immune-mediated clearance. These reagents facilitate advanced studies in gene function, RNA interference, and gene therapy within a physiologically relevant immune environment.
Pharmacology, Toxicology, and Preclinical Testing
CD57BL mice are integral to preclinical pharmacology and toxicology studies that require an intact immune system. They are used to evaluate the safety, efficacy, and immunogenicity of novel therapeutics, including small molecules, biologics, and nucleic acid-based drugs. Their immune competence allows comprehensive assessment of immune-related adverse events, cytokine release, and systemic toxicities. Altogen Labs offers contract research services utilizing CD57BL mice to provide robust pharmacodynamic and toxicological data, supporting drug development and regulatory compliance.
Supportive Products and Research Services
Altogen Biosystems supplies a range of transfection reagents and kits tailored for CD57BL mice, designed to optimize nucleic acid and protein delivery in immunocompetent animals. Altogen Labs complements these offerings with specialized in vivo research services, including xenograft establishment, gene delivery, therapeutic efficacy testing, and endpoint molecular analyses using the CD57BL model. Their expertise ensures reproducible results and accelerates translational research in immunology and oncology.
Learn More at Altogen Labs
For further information on CD57BL mouse models, in vivo gene delivery, and related research services, visit Altogen Labs at https://altogenlabs.com/xenograft-models/.
CB17 Mouse Model
Overview of the CB17 Strain
The CB17 mouse is an inbred strain extensively used in biomedical research, particularly in immunology and oncology. This strain carries a mutation that causes severe combined immunodeficiency (SCID), resulting in the absence of functional T and B lymphocytes while retaining natural killer (NK) cell activity. CB17 mice typically have a white coat and are genetically stable, making them a reliable and reproducible model for studies involving immune system deficiency, human cell and tissue engraftment, and cancer xenografts.
Immunological Characteristics and Research Significance
CB17 mice lack mature T and B cells due to a defect in V(D)J recombination, which is critical for the development of antigen receptors. Despite this, their NK cells remain active, providing partial innate immune surveillance. The SCID phenotype makes CB17 mice highly permissive hosts for engraftment of human cells and tissues, as well as tumor xenografts, without rejection mediated by adaptive immunity. Researchers utilize CB17 mice to study human immune cells in vivo, evaluate tumor biology, and investigate therapies that target human tissues or malignancies.
Applications in Xenograft and Cancer Research
The CB17 strain serves as a foundational model for human tumor xenografts and patient-derived xenograft (PDX) studies. Its immunodeficient status allows human tumor cells from various cancer types—including breast, colon, lung, and hematologic malignancies—to be implanted and studied in a live animal context. CB17 mice facilitate the evaluation of novel anticancer drugs, tumor progression mechanisms, and metastasis. The residual NK activity is an important consideration, as it may affect engraftment success and experimental outcomes.
Use in In Vivo Transfection and Gene Therapy Studies
CB17 mice are valuable for in vivo delivery of nucleic acids such as siRNA, shRNA, plasmid DNA, and CRISPR-Cas9 components. Their immunodeficient environment reduces immune clearance of these agents, enhancing gene expression or silencing efficiency in target tissues. Altogen Biosystems provides a suite of in vivo transfection reagents optimized for use with CB17 mice, supporting efficient and reproducible delivery with minimal toxicity. These tools enable functional genomics studies and therapeutic development involving gene modulation in immunodeficient hosts.
Pharmacology and Toxicology Applications
Due to their SCID phenotype, CB17 mice are ideal for preclinical pharmacology and toxicology research involving human xenografts and biological therapeutics. Their lack of adaptive immunity allows detailed assessment of drug effects on human tumors and tissues without confounding immune responses. This strain supports pharmacokinetic, pharmacodynamic, and safety evaluations critical for drug development pipelines. Altogen Labs offers specialized services utilizing CB17 mice to generate reliable preclinical data in oncology and immunodeficiency contexts.
Support from Altogen Biosystems and Altogen Labs
Altogen Biosystems offers transfection reagents and kits specifically formulated for CB17 mouse applications, including lipid- and polymer-based delivery systems tailored for immunodeficient models. Altogen Labs complements these products with contract research services focused on xenograft establishment, in vivo gene delivery, therapeutic efficacy testing, and molecular analyses using CB17 mice. Their integrated approach ensures high-quality, reproducible results to advance translational and preclinical research.
Learn More at Altogen Labs
To explore detailed services and products related to CB17 mouse xenograft models and in vivo transfection, visit Altogen Labs at https://altogenlabs.com/xenograft-models/.
NSG Mouse Model
Overview of the NSG Strain
The NSG mouse, short for NOD scid gamma, is a profoundly immunodeficient inbred strain that combines multiple genetic mutations leading to severe immune compromise. These mice lack functional T cells, B cells, and natural killer (NK) cells, making them one of the most immunodeficient mouse models available. Their white coat and stable genetics contribute to their widespread use in xenotransplantation, humanized mouse models, and preclinical research where an absence of host immune response is essential for engraftment and study of human cells and tissues.
Immunodeficiency Profile and Research Utility
NSG mice possess defects in multiple components of the immune system. They harbor the severe combined immunodeficiency (scid) mutation, which eliminates mature T and B lymphocytes, and a null mutation in the interleukin-2 receptor gamma chain gene (IL2rg null), which leads to a lack of NK cell development. This triple immune deficiency creates an environment highly permissive to engraftment of human hematopoietic stem cells, peripheral blood mononuclear cells, and various tumor types. As a result, NSG mice serve as an optimal platform for modeling human immune system function, infectious disease, cancer progression, and immunotherapy.
Applications in Humanized Mouse and Xenograft Models
Due to their profound immune deficiency, NSG mice are the preferred choice for generating humanized mouse models. Transplantation of human hematopoietic stem cells into NSG mice leads to multilineage human immune system reconstitution, enabling the study of human immune responses in vivo. Additionally, NSG mice are widely used for patient-derived xenografts (PDX) and tumor xenograft models across diverse cancer types. Their lack of NK cells enhances engraftment efficiency and tumor growth, making them invaluable for evaluating anticancer drugs, immune therapies, and disease mechanisms.
Role in In Vivo Transfection and Gene Editing Studies
The NSG strain’s immunodeficient background allows enhanced in vivo delivery of nucleic acids, including siRNA, miRNA, plasmid DNA, and gene editing tools such as CRISPR-Cas9, without interference from host immune clearance. Altogen Biosystems offers transfection reagents tailored for NSG mice, optimized for efficient intracellular delivery and minimal toxicity. These reagents support functional genomics and therapeutic gene modulation studies in a humanized or xenograft context, facilitating translational research in immunology, oncology, and regenerative medicine.
Preclinical Pharmacology and Toxicology Research
NSG mice play a pivotal role in preclinical pharmacology and toxicology testing involving human cell engraftment. Their immunodeficient state enables evaluation of therapeutic candidates in humanized or xenograft models without immune rejection. NSG mice allow detailed assessment of drug efficacy, pharmacokinetics, pharmacodynamics, and safety profiles relevant to human biology. Altogen Labs provides comprehensive contract research services leveraging NSG mice for advanced in vivo testing and biomarker development, supporting regulatory submissions and drug development pipelines.
Products and Services from Altogen Biosystems and Altogen Labs
Altogen Biosystems manufactures a range of delivery reagents specifically formulated for use in NSG mice, including liposomal, polymeric, and nanoparticle transfection systems engineered for immunodeficient models. Altogen Labs complements these products with expert in vivo research services, such as xenograft implantation, in vivo gene delivery, therapeutic efficacy evaluation, and molecular endpoint analyses using NSG mice. Their integrated solutions help researchers achieve robust, reproducible data in complex humanized and cancer models.
Learn More at Altogen Labs
For additional information on NSG mouse models and specialized research services, visit Altogen Labs at https://altogenlabs.com/xenograft-models/.
Swiss Nude Mouse Model
Overview of the Swiss Nude Strain
The Swiss Nude mouse is an outbred immunodeficient strain characterized by the absence of a thymus, resulting in a lack of functional T lymphocytes. This strain exhibits a nude, hairless phenotype and a white coat. Swiss Nude mice maintain normal B cell and natural killer (NK) cell populations, which distinguishes them from other immunodeficient models. Their unique immune profile and robust engraftment capacity make them a valuable tool in cancer research, immunology, and regenerative medicine.
Immunological Characteristics and Research Applications
Due to thymic aplasia, Swiss Nude mice are severely deficient in T cell-mediated immunity, rendering them unable to mount adaptive immune responses. However, their intact B cell and NK cell functions allow partial innate immunity, which can influence engraftment outcomes and disease progression. Researchers employ Swiss Nude mice extensively for studies requiring T cell deficiency, including tumor xenograft models, infectious disease research, and transplantation biology. Their outbred genetics provide genetic diversity, enhancing model robustness in preclinical studies.
Use in Cancer Xenograft and Tumor Biology Studies
Swiss Nude mice are widely used as hosts for human tumor xenografts due to their immunodeficient status. These models facilitate investigations into tumor growth, metastasis, angiogenesis, and response to anticancer therapies. The presence of NK cells requires careful consideration when evaluating tumor engraftment and immune interactions. Swiss Nude mice support evaluation of chemotherapeutic agents, targeted therapies, and immunomodulatory drugs, providing critical insights into tumor biology and treatment efficacy.
Role in In Vivo Transfection and Gene Delivery
The Swiss Nude mouse’s immune profile enables efficient in vivo delivery of nucleic acids, including siRNA, miRNA, plasmid DNA, and gene editing components. Altogen Biosystems offers specialized in vivo transfection reagents optimized for use in Swiss Nude mice, ensuring enhanced nucleic acid uptake, minimal toxicity, and reproducible gene modulation. These tools support studies in gene function, therapeutic gene silencing, and molecular pathway analysis within an immunodeficient context.
Preclinical Pharmacology and Toxicology Studies
Swiss Nude mice are instrumental in preclinical pharmacology and toxicology research involving human xenografts and biologics. Their T cell deficiency allows for the assessment of therapeutic agents in a compromised immune setting while retaining innate immune functions. This balance aids in modeling drug effects on tumor progression and host response. Altogen Labs provides contract research services utilizing Swiss Nude mice for pharmacodynamic evaluations, safety profiling, and biomarker discovery.
Support from Altogen Biosystems and Altogen Labs
Altogen Biosystems supplies a range of in vivo transfection reagents compatible with Swiss Nude mice, including liposomal and polymer-based delivery systems tailored for immunodeficient models. Altogen Labs offers comprehensive in vivo research services, encompassing xenograft establishment, gene delivery optimization, therapeutic efficacy testing, and molecular endpoint analysis in Swiss Nude mice. Their integrated solutions enable high-quality, reproducible research outcomes in oncology and immunology.
Learn More at Altogen Labs
For further details on Swiss Nude mouse models and in vivo research services, visit Altogen Labs at https://altogenlabs.com/xenograft-models/.